Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | JAGSNPHARM Jagsonpal Pharmaceuticals Limited Pharma · Small | WINDLAS Windlas Biotech Limited Pharma · Small | BAJAJHCARE Bajaj Healthcare Limited Pharma · Small | ANUHPHR Anuh Pharma Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 57 | 46 | 29 | 50 |
| Verdict | FAIR VALUE | FAIR VALUE | OVERVALUED | FAIR VALUE |
| Style | Financial Turnaround | Financial Turnaround | OVERVALUED | FAIR_VALUE |
| Piotroski | 8/9 | 8/9 | 7/9 | 6/9 |
| Valuation | 7/30 | 10/30 | 5/30 | 16/30 |
| Growth | 16/25 | 12/25 | 2/25 | 12/25 |
| Quality | 12/20 | 2/20 | 0/20 | 2/20 |
| Balance Sheet | 12/15 | 13/15 | 9/15 | 12/15 |
| Cash Flow | 5/10 | 4/10 | 7/10 | 4/10 |
| Price | ₹201.75 | ₹835.4 | ₹292.1 | ₹77.55 |
| P/E | 29.30 | 25.30 | 21.10 | 18.50 |
| P/B | 4.83 | 2.96 | 1.87 | 2.16 |
| ROE | 17.30% | 12.20% | 9.40% | 12.10% |
| ROCE | 22.70% | 15.90% | 11.50% | 15.90% |
| Debt / Equity | 0.03 | 0.06 | 0.47 | 0.00 |
| FCF Yield | 0.84% | 0.77% | 1.01% | 1.98% |
| Dividend Y | 1.26% | 0.71% | 0.34% | 1.98% |
| Altman Z | 8.98 | 5.58 | 3.55 | 4.96 |
| Promoter % | 67.89% | 63.31% | 58.29% | 71.79% |
| Mkt Cap (₹Cr) | 1308.00 | 1680.00 | 992.00 | 759.00 |
| Graham # | ₹77.2 | ₹441.41 | ₹128.99 | ₹56.9 |
| Fair PE | 42.0 | 42.0 | 3.8 | 42.0 |
| MoS % | +25.3% | +36.8% | -1555.4% | +55.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startJAGSNPHARM34
WINDLAS77
BAJAJHCARE74
ANUHPHR35